Literature DB >> 7792034

Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey.

B Hoen1, M Kessler, D Hestin, D Mayeux.   

Abstract

All adult patients from 13 dialysis centres were prospectively followed up for 6 months in an attempt to appraise the current risk factors for bacterial infections in stable chronically haemodialysed patients. Parameters recorded as potential risk factors for BI were age, gender, cause of renal failure, time elapsed since the start of dialysis, history of transplantation, recent surgical procedure, previous bacterial infection, current immunosuppressive or erythropoietin therapy, type of angioaccess device, and serum ferritin level. Six hundred and seven patients (mean age 56.5 years, range 18-85) were enrolled in the study. Mean time elapsed since the start of dialysis was 4.7 years. One hundred and eighteen patients had developed at least one bacterial infection during the study period whereas 489 had remained free of bacterial infection at the end of the follow-up. In multivariate analysis three parameters were found to be significant and independent risk factors for bacterial infection: previous history of bacterial infection (at least one versus no previous episode), type of angioaccess device (catheter versus native fistula), and elevated serum ferritin level (greater versus lower than 500 micrograms/l). These results support the evidence that impaired host defences in chronic haemodialysis patients may be secondary to the dialysis procedure and suggest that the incidence of bacterial infection in these patients may be further reduced by appropriate supportive therapy.

Entities:  

Mesh:

Year:  1995        PMID: 7792034

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  25 in total

1.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

2.  An experience of vascular access for hemodialysis in Brazil.

Authors:  Guilherme Centofanti; Eliane Y Fujii; Rafael N Cavalcante; Edgar Bortolini; Luiz Carlos de Abreu; Vitor E Valenti; Adilson C Pires; Hugo Macedo; Yumiko R Yamazaki; Soraya G Audi; José R Cisternas; João R Breda; Valdelias X Pereira; Edson N Fujiki; João A Correa
Journal:  Int Arch Med       Date:  2011-05-15

3.  Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Sheila Coakley; Carolyn Abitbol; Brenda Montane; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

4.  Increased serum iron levels and infectious complications after liver transplantation.

Authors:  Jennifer K Chow; Barbara G Werner; Robin Ruthazer; David R Snydman
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

5.  Spondylodiscitis in patients under haemodyalisis.

Authors:  Ana Maria Cervan; Juan de Dios Colmenero; Alfonso Del Arco; Francisco Villanueva; Enrique Guerado
Journal:  Int Orthop       Date:  2011-12-03       Impact factor: 3.075

Review 6.  T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance.

Authors:  Ruud Wj Meijers; Michiel Gh Betjes; Carla C Baan; Nicolle Hr Litjens
Journal:  World J Nephrol       Date:  2014-11-06

Review 7.  Iron and infection in hemodialysis patients.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  Semin Dial       Date:  2013-12-12       Impact factor: 3.455

8.  Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Authors:  Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

9.  Candida bloodstream infections in hemodialysis recipients.

Authors:  Vasilios Pyrgos; Kathryn Ratanavanich; Nancy Donegan; Judith Veis; Thomas J Walsh; Shmuel Shoham
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

Review 10.  Safety issues with intravenous iron products in the management of anemia in chronic kidney disease.

Authors:  Amir Hayat
Journal:  Clin Med Res       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.